Found: 35
Select item for more details and to access through your institution.
The Landscape of Immunotherapy in Advanced NSCLC: Driving Beyond PD-1/PD-L1 Inhibitors (CTLA-4, LAG3, IDO, OX40, TIGIT, Vaccines).
- Published in:
- Current Oncology Reports, 2021, v. 23, n. 11, p. 1, doi. 10.1007/s11912-021-01124-9
- By:
- Publication type:
- Article
Impact of Baseline Versus Intercurrent Steroids Administration on Upfront Chemo-Immunotherapy for Advanced Non-Small Cell Lung Cancer (NSCLC).
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 18, p. N.PAG, doi. 10.3390/ijms231810292
- By:
- Publication type:
- Article
Drug-induced colitis on BRAF and MEK inhibitors for BRAF V600E-mutated non-small cell lung cancer: a case report.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 1, p. 190, doi. 10.1007/s10637-021-01166-7
- By:
- Publication type:
- Article
A case of nivolumab-related cholangitis and literature review: how to look for the right tools for a correct diagnosis of this rare immune-related adverse event.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 1, p. 144, doi. 10.1007/s10637-017-0484-6
- By:
- Publication type:
- Article
PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non–small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. 423, doi. 10.1016/j.cllc.2021.03.005
- By:
- Publication type:
- Article
Overcoming Primary Resistance to PD-1 Inhibitor With Anti-PD-L1 Agent in Squamous-Cell NSCLC: Case Report.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359211058391
- By:
- Publication type:
- Article
Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211058391
- By:
- Publication type:
- Article
Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211058391
- By:
- Publication type:
- Article
Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920954802
- By:
- Publication type:
- Article
New disappearance of complicated atheromatous plaques on rechallenge with PD-1/PD-L1 axis blockade in non-small cell lung cancer patient: follow up of an unexpected event.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920913801
- By:
- Publication type:
- Article
Atezolizumab in a C o H ort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal Subtyp E s (CHANCE trial).
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920915983
- By:
- Publication type:
- Article
KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919885540
- By:
- Publication type:
- Article
Development and validation of a new tool to estimate early mortality in patients with advanced cancer treated with immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03836-w
- By:
- Publication type:
- Article
Immune-mediated cholangitis: is it always nivolumab’s fault?
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
The Palliative Prognostic (PaP) Score without Clinical Evaluation Predicts Early Mortality among Advanced NSCLC Patients Treated with Immunotherapy.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5845, doi. 10.3390/cancers14235845
- By:
- Publication type:
- Article
Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes.
- Published in:
- Cancers, 2022, v. 14, n. 14, p. N.PAG, doi. 10.3390/cancers14143472
- By:
- Publication type:
- Article
IFN-γ and CD38 in Hyperprogressive Cancer Development.
- Published in:
- Cancers, 2021, v. 13, n. 2, p. 309, doi. 10.3390/cancers13020309
- By:
- Publication type:
- Article
The Mechanisms of PD-L1 Regulation in Non-Small-Cell Lung Cancer (NSCLC): Which Are the Involved Players?
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3129, doi. 10.3390/cancers12113129
- By:
- Publication type:
- Article
MET and Small-Cell Lung Cancer.
- Published in:
- Cancers, 2014, v. 6, n. 4, p. 2100, doi. 10.3390/cancers6042100
- By:
- Publication type:
- Article
Fatal case of hepatic portal venous gas following palliative stenting and chemotherapy for occlusive advanced colorectal cancer.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Pembrolizumab in the treatment of metastatic non-small cell lung cancer: a review of current evidence.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2017, v. 11, n. 9, p. 353, doi. 10.1177/1753465817725486
- By:
- Publication type:
- Article
Meningitis Caused by Toscana Virus Is Associated with Strong Antiviral Response in the CNS and Altered Frequency of Blood Antigen-Presenting Cells.
- Published in:
- Viruses (1999-4915), 2015, v. 7, n. 11, p. 5831, doi. 10.3390/v7112909
- By:
- Publication type:
- Article
Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Peripheral nervous system adverse events associated with immune checkpoint inhibitors.
- Published in:
- Journal of Neurology, 2023, v. 270, n. 6, p. 2975, doi. 10.1007/s00415-023-11625-1
- By:
- Publication type:
- Article
Paraneoplastic vs. non-paraneoplastic anti-Hu associated dysmotility: a case series and literature review.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 3, p. 1182, doi. 10.1007/s00415-021-10577-8
- By:
- Publication type:
- Article
Correction to: Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL).
- Published in:
- 2021
- By:
- Publication type:
- corrected article
Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL).
- Published in:
- British Journal of Cancer, 2020, v. 123, n. 1, p. 26, doi. 10.1038/s41416-020-0845-3
- By:
- Publication type:
- Article
Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL).
- Published in:
- 2020
- By:
- Publication type:
- journal article
From Development to Place in Therapy of Lorlatinib for the Treatment of ALK and ROS1 Rearranged Non-Small Cell Lung Cancer (NSCLC).
- Published in:
- Diagnostics (2075-4418), 2024, v. 14, n. 1, p. 48, doi. 10.3390/diagnostics14010048
- By:
- Publication type:
- Article
Genetic and Functional Characterization of Toll-Like Receptor Responses in Immunocompetent Patients With CMV Mononucleosis.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2020, v. 10, p. N.PAG, doi. 10.3389/fcimb.2020.00386
- By:
- Publication type:
- Article
Psychiatric Adverse Reactions to Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer: Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 1, p. 43, doi. 10.1007/s11523-021-00865-8
- By:
- Publication type:
- Article
Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance.
- Published in:
- Targeted Oncology, 2020, v. 15, n. 4, p. 449, doi. 10.1007/s11523-020-00738-6
- By:
- Publication type:
- Article
Clinical retrospective analysis of erlotinib in the treatment of elderly patients with advanced non-small cell lung cancer.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Predictors of Survival to Immunotherapy and Chemoimmunotherapy in Non-Small Cell Lung Cancer: A Meta-Analysis.
- Published in:
- 2023
- By:
- Publication type:
- journal article